MediWound Ltd - MDWD Enterprise Value to EBITDA Ratio
MediWound Ltd. is developing its burn therapy segment through partnerships with hospitals and biotech holdings. This chart's price action reflects an EV/EBITDA multiple of 0.00. The business relies on the expansion of NexoBrid, which is in high demand within emergency and military medicine. However, the company faces pressure from global behemoths capable of scaling the production of similar enzyme-based drugs more rapidly.
mediwound.com - analytical breakdowns and key metrics (MDWD)
- market price and analyst price targets:
- issuer market value details:
- business book valuation details:
- debt obligations and liquidity statistics:
- business earnings and investment ratios data:
MDWD - Net Profit|Expected Profit MediWound Ltd.|MDWD - Price to Earnings Multiple|Forward P/E Multiple MediWound|MDWD - Growth-Adjusted P/E Ratio|Enterprise Value to EBITDA Ratio MediWound Ltd|MDWD - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months MediWound Ltd.|MDWD - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months mediwound.com|MDWD - Net earnings per one share growth for the current year|Earnings growth forecast for next year MediWound Ltd.
Comprehensive company analysis:MediWound, Ltd. (MDWD)
Rising demand for MediWound Ltd. (MDWD) enzymatic preparations is expanding its hospital distribution network. The EV/EBITDA metric, including depreciation and debt, correlates the total enterprise value with operating profit before taxes, depreciation, and amortization. This chart's price action allows market value to be stripped of accounting distortions and the impact of debt load. The stability of this multiple confirms the company's fundamental resilience amid the expansion of medical standards.
Competitors of MediWound Ltd. (MDWD)
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HCA Healthcare HCA|THC: Enterprise Value to Operating Income Before Depreciation|FMS: Enterprise Value to EBITDA Ratio|solventum.com - Enterprise Value to Operating Income Before Depreciation Ratio|Encompass Health Corporation (EHC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Universal Health Services, Inc.|DVA (DaVita Inc) - EV/EBITDA Multiple|Company Value to EBITDA RadNet Management RDNT|EV/EBITDA Multiple OPCH|surgerypartners.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple PINC (Premier)|Total Company Value to Operating Income Before Depreciation Ratio National Vision Holdings, Inc. (EYE)|PGNY: Enterprise Value to EBITDA Ratio|Ardent Health Corp (ARDT) - Enterprise Value to EBITDA Ratio|Select Medical (SEM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA astranahealth.com (ASTH)|Enterprise Value to EBITDA Ratio MD|EV/EBITDA Multiple US Physical Therapy Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Pennant Group Inc (PNTG)|Organogenesis Corp - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple NUTX (Nutex Health Inc.)|AUNA: Enterprise Value to Operating Income Before Depreciation|SBC: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation EOLS (Evolus Inc)|Community Health Systems Inc (CYH) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SKIN (BeautyHealth) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio BTMD|JYNT (thejoint.com) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple DCGO|p3hp.org - Enterprise Value to Operating Income Before Depreciation|Gain Therapeutics, Inc. - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio euda.com (EUDA)|BMGL - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CollPlant Biotechnologies (CLGN) - Enterprise Value to EBITDA Ratio|CUPR: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation CCM|Enterprise Value to EBITDA Ratio AMS|Enterprise Value to EBITDA Ratio MEDIROM Corp (MRM)|EV/EBITDA Multiple ALBT|dih.com - Enterprise Value to Operating Income Before Depreciation|Carmell Therapeutics - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NIVF (NewGenIvf Group)|ATIP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation CMAX (CareMax, Inc)|KDLY: EV/EBITDA Multiple|Company Value to EBITDA modivcare.com (MODV)|NVOS (Novo Integrated Sciences, Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple SunLink Health Systems, Inc|Enterprise Value to EBITDA Ratio BACK (IMAC Regeneration Centers)
